Bevacizumab and gamma knife radiosurgery for first-recurrence glioblastoma

ConclusionThis study demonstrates that the combined use of bevacizumab with concurrent stereotactic radiosurgery can have improve survival in patients with rGBM.

http://link.springer.com/10.1007/s11060-023-04524-y

Source: Journal of Neuro-Oncology - January 4, 2024 Category: Cancer & Oncology Source Type: research